Meeting documents & Info


About the Meeting

Objectives of the meeting

IABS and Vac2Vac are honoured to be organizing a Global Congress that will focus on replacement of in vivo testing of vaccines by in vitro methods with utilization of new and improved technologies. Progresses made with analytical tools and their applications have contributed to development of fast, precise and highly reliable in vitro tests that will allow batch to batch release of vaccines by consistency approach. Recent case studies on specific vaccines will be reviewed, and ongoing as well as future studies on other vaccines will be discussed. A particular emphasis will be placed on global coordination in areas of manufacturing and testing practices, and regulatory acceptance, with the goal of reducing time to market and increasing global access to vaccines. Participation from all of these areas of vaccine development, especially from LMICs and GAVI countries, is strongly encouraged. Bangkok has been selected as the site for this Congress because of its location amid countries with emerging vaccine producers and growing needs for vaccines.

We are honoured to have pledges of support from global foundations and partners from emerging economies.

Scientific committee

Dr.Coenraad Hendriksen, Chair Scientific Committee
Institute for Translational Vaccinology, The Netherlands
Dr. Supaporn Phumianmorn, co-Chair Scientific Committee
Department of Medical Sciences, Ministry of Public Health, Thailand
Dr. Gautam Sanyal
Vaccine Analytics, LLC, USA
Dr. Sunil Kumar Goel
Serum Institute India. India
Dr. Karl-Heinz Buchheit
European Directorate for the Quality of Medicines & HealthCare (EDQM), France
Dr. Laura Viviani
Humane Society International (HIS), Italy
Dr. Catrina Stirling
Zoetis, United Kingdom
Dr. Marlies Halder
Dr. Yeowon Sohn
Seoul National University, Republic of Korea
Dr. Denis Lambrigts
GSK Biologicals, Belgium
Dr. Wassana Wijagkanalan
Government Affairs Manager, Thailand
Dr. Richard Hill
International Alliance for Biological Standardization (IABS), USA
Dr. Mario Landys
Cuerdo Finlay Institute, Cuba
Dr. Koji Ishii
National Institute of Infectious Diseases, Japan
Dr. Robin Levis
Dr. Ai-Ping Hsu
Animal Health Research Institute, Taiwan
Dr. Thitawat Chanthaworn
National Institute of Animal Health, Thailand
Dr. Jim Webster
Ruakura Research Centre, New Zealand
Dr. Hilde Depraetere
European Vaccine Initiative (EVI), Germany
Dr. Sylvie Uhlrich
Sanofi-Pasteur Lyon, France
Dr. Carmen Jungbaeck
International Alliance for Biological Standardization (IABS), USA
Dr. Scott Craig
Therapeutic Goods Administrator, Australia
Dr. Bob Sitrin
Vaccine Development Global Program – APTH, USA